Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy
- Citation:
- Clin Cancer Res vol 19 (2) 491-499
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Book Volume:
- 2
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- F32 CA165823, P50CA125183, U01 GM061393, P50 CA125183, U10 CA031946, U01GM61393, U10 CA033601, T32 CA009594, P30 CA008748, F32CA165823, U01 GM061390, U19 GM061390, U01GM61390, T32 CA009566, T32CA009594, CA31946, T32CA009566
- Corr. Author:
- Authors:
- Heather E. Wheeler Eric R. Gamazon Claudia Wing Uchenna O. Njiaju Chidiamara Njoku R. Michael Baldwin Kouros Owzar Chen Jiang Dorothy Watson Ivo Shterev Michiaki Kubo Hitoshi Zembutsu Eric Winer Clifford Hudis Lawrence N. Shulman Yusuke Nakamura Mark J. Ratain Deanna L. Kroetz Nancy J. Cox M. Eileen Dolan
- Networks:
- Study
- CALGB-40101
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- pharmacogenomics, clinical trial, cell lines, paclitaxel, genome-wide association